Keefe Bruyette raised the firm’s price target on Globe Life (GL) to $162 from $160 and keeps an Outperform rating on the shares. The primary near-term risk is a lack of further catalysts, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Globe Life Inc. Reports Strong Q3 Earnings Amid Challenges
- Globe Life price target raised to $158 from $150 at Truist
- Globe Life price target lowered to $170 from $172 at Wells Fargo
- Globe Life Inc. Reports Strong Q3 2025 Earnings
- Globe Life’s Strong Financial Performance and Promising Outlook Justify Buy Rating